Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF) (the “Company” or “Pure Global” or “PURE”), a vertically integrated growth-oriented life sciences cannabis company, announced today that its shares are now listed on the Berlin, Munich and Stuttgart stock exchanges under the “WKN:A2JQ26” and the ticker symbol “1QS”. The company anticipates its Frankfurt listing imminently. The company’s shares continue to be listed on the TSXV under the ticker “PURE” and on the OTC market in the US under the ticker symbol “PRCNF”.
The company has also announced that is has appointed Deutsche Gesellschaft für Wertpapieranalyse GmbH (“DGWA” – www.dgwa.org), a boutique European investment and financial markets consulting firm based in Frankfurt, Germany to support the Company’s existing German listing. The appointment of DGWA, an accomplished Frankfurt and Berlinbased Investment Banking Boutique will support Pure Global in expanding the profile of the Company’s global investor base across Europe.
“Our listing in Germany is an important milestone for Pure Global as we continue to expand our international awareness and investor base. This will allow European investors to participate in PURE’s ongoing significant growth and expansion,” said Malay Panchal, President & CEO of Pure Global. “Pure Global Cannabis is very well positioned to grow within the EU and across the global cannabis market as countries continue to adopt new cannabis regulations.”
Mr Stefan Müller is the CEO and founder of DGWA and graduated as a banker, beginning his career at Dresdner Bank AG as senior vice president of global equity trading. He has held senior positions with Equinet AG, Bankhaus Sal Oppenheim (largest European private bank at that time) as head of global proprietary trading and managing partner at Proprietary Partners AG, a Swiss based hedge fund advisory company.
Importantly DGWA consults to various companies, investors, institutions and federal organizations regarding their investment strategy.
Commenting on DGWA’s appointment, Mr Müller said:
“DGWA is pleased to be working with the Pure Global team as they expand their presence in the European market. There is significant interest within Europe for regulated medical cannabis companies and we believe Pure Global Cannabis is one of the most attractive companies listed today. Pure Global Cannabis will be of particular interest to European retail, institutional and strategic investors as many are seeking greater exposure to global cannabis revolution.”
About Pure Global Cannabis
Pure Global Cannabis Inc. (TSXV:PURE; OTC: PRCNF) is a vertically-integrated, growth-oriented life sciences cannabis company led by experienced pharma-industry, horticultural, consumer packaged goods (CPG), and supply chain experts. The Company’s wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR) focused on producing cannabis products for medical, wellness, health & beauty, natural health, and future legal adult use markets.
About DGWA – www.dgwa.org
Deutsche Gesellschaft für Wertpapieranalyse GmbH (“DGWA”) is a German Institute for asset management and a boutique European investment and financial markets consulting firm based in Frankfurt and Berlin, Germany. The management team have a 25-year track record in trading, investing and analysing SME’s around the world. DGWA has been involved in over 250 IPO’s, financings, bond issues, dual listings and corporate finance transactions as well as coordinating roadshows and awareness campaigns.
This news release contains certain forward-looking statements, including, but not limited to, statements about Pure Global’s future plans and intentions. Wherever possible, words such as “may”, “will”, “should”, “could”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict” or “potential” or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management’s current beliefs and are based on information currently available to management as at the date hereof.
Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, Pure Global cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and Pure Global assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
For further information: regarding Pure Global, please contact: Stephen Pynn, VP Corporate Development, Telephone: 1-866-899-PURE (7873), E-mail: firstname.lastname@example.org; Malay (Mel) Panchal, President & CEO, Telephone: 1-866-899-PURE (7873), E-mail: email@example.com
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).